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More than 20 years ago, Shoemaker and coworkers [1,2]
observed that perioperative alterations in oxygen transport
were closely related to the development of organ failure and
death. Subsequently, several studies reported that
perioperative hemodynamic optimization guided by the
pulmonary artery catheter may decrease morbidity and
mortality [3–6]. Nevertheless, the use of the pulmonary artery
catheter has been challenged because of its invasiveness
and possibly the unwarranted interventions that may result
from its use [7].
In a recent issue of the New England Journal of Medicine,
Sandham and coworkers [8] reported the results of a
multicenter Canadian study that investigated the effects of
right heart catheterization on perioperative complications in
high-risk patients undergoing noncardiac surgery. From 1990
to 1999, those authors randomly allocated 1994 American
Society of Anesthesiologists class III and IV patients to
conventional monitoring and therapy or to right heart
catheterization and hemodynamic optimization. They
observed that survival (up to 1 year of follow up) and hospital
stay did not differ between the two groups. The incidence of
perioperative complications was similar in both groups,
except for an increased incidence of pulmonary embolism in
the pulmonary artery catheter group.
Although Sandham and coworkers [8] must be commended
for their important undertaking, the study raises a number of
important concerns. First, although the authors claimed that
no patient selection was performed, the inclusion rate of a
mean of only 22 patients/center per year was surprisingly
low. For example, close to 1000 patients with American
Society of Anesthesiologists class III and IV are operated on
each year in our 760-bed institution. One of the inclusion
criteria was the commitment of the surgeon and the
anesthesiologist to adhere to the study concept; the most
severely ill patients might therefore have been excluded, and
this may explain the unexpectedly low mortality rate among
the patients studied (a 15% mortality rate was included in the
power calculation of the study).
Second, although the authors claimed that preoperative
optimization was performed, in the vast majority of patients
the goals were achieved only postoperatively (Fig. 2 of the
paper, which reported the maximal value for the
corresponding period) [8]. Only in a very limited number of
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Abstract
Recent years have seen the place of the pulmonary artery catheter in intensive care increasingly
challenged, with one recent study reporting no difference in outcome in patients treated with or without
a pulmonary artery catheter. However, this study has several methodological flaws and, although
pulmonary artery catheterization should not be performed routinely on all patients, when used correctly
by trained personnel in selected patients the pulmonary artery catheter continues to provide valuable
information.
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patients were the resuscitation goals achieved in the
preoperative and intraoperative periods. Unfortunately, the
time from catheter insertion to initiation of surgery was not
mentioned. Also, there was no indication as to when these
values were achieved and for how long. Indeed, the time
allocated to achieve optimization is crucial, because insertion
of a catheter just before the beginning of surgery does not
allow sufficient time to achieve hemodynamic optimization,
and the catheter will then only be used to observe
hemodynamic alterations. The low rate of attainment of
hemodynamic goals contrasts with previous studies reporting
beneficial effects of perioperative optimization. For example,
all of the patients in the study conducted by Wilson and
colleagues [5] achieved an oxygen delivery of at least
600 ml/min per m2 throughout the study. In addition, the
protocol used to achieve the hemodynamic end-points is not
well defined. The authors used fluids and vasoactive agents,
but the type and doses of these agents were not specified. It
is likely that these elements varied from one institution to
another.
Third, the incidence of pulmonary embolism may have been
different in the two groups but it is surprising to read that no
pulmonary embolism was diagnosed in the control group. If a
pulmonary embolism had been diagnosed in only two of the
997 patients in the control group (certainly a realistic figure),
then the statistical significance would disappear. Of note, the
physicians involved in the diagnosis of pulmonary embolism
were not blinded to catheter insertion. This may
counterbalance the somewhat lower incidence of renal failure
in the group of patients receiving the pulmonary artery
catheter. One should also note that chance alone can explain
one positive P value at the 5% confidence level when more
than 20 statistical comparisons are performed.
Fourth and most important, the goals were not protocolized
and were less than optimal. Why was there a maximal value
for cardiac output? Were patients supposed to receive a
β-blocking agent when cardiac output exceeded
4.5 l/min per m2? Also, why was such a high level (18 mmHg)
of pulmonary artery occlusion pressure taken as an end-
point? The analysis of the cardiac function curves could have
resulted in a lower pulmonary artery occlusion pressure, and
on this basis a lesser risk for pulmonary oedema. Also why
was the mixed venous oxygen saturation (SvO2) not taken as
a valuable (and perhaps the best [9,10]) end-point? SvO2
reflects the balance between oxygen supply and demand,
and it is particularly useful when large changes in oxygen
demand are expected to occur (e.g. in anesthesia,
hypothermia, pain, etc.). The monitoring of SvO2 may also
limit the risk of over-treatment with vasoactive agents,
because high doses of inotropic agents may worsen the
balance between oxygen supply and demand even though
cardiac output increases [10]. Oxygen extraction has already
been used in various groups of surgical patients to assess
the adequacy of resuscitation at the time of the protocol
design [11–16]. Recently, Rivers and coworkers [17]
reported that mortality can be decreased when the central
venous oxygen saturation is used to guide therapy in patients
with severe sepsis and septic shock.
We believe that this important study highlights again that
pulmonary artery catheters should not be inserted routinely in
patients with limited risk for death [18] but it does not imply
that it should be avoided in patients with a higher
perioperative risk for death. Less invasive monitoring
techniques, such as esophageal Doppler or lithium or
transpulmonary dilution, may be required to optimize stroke
volume in patients with limited risk for death [19].
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